— EXPAREL is the only FDA-approved single-dose regional analgesic to safely demonstrate four days of superiority versus bupivacaine in two clinical studies — — New indications for use as an adductor ...

In both studies, Exparel achieved a statistically significant reduction in cumulative pain scores from 0 to 96 hours compared with bupivacaine hydrochloride. The Food and Drug Administration (FDA) has ...

Patients who received interscalene brachial plexus block plus soft tissue infiltration with Exparel when undergoing primary shoulder arthroplasty used significantly more narcotics postoperatively and ...

Please provide your email address to receive an email when new articles are posted on . Teratani examined data from the double-masked trial of 128 shoulders that received ARCR. Patients were equally ...

The Food and Drug Administration (FDA) has approved the use of Exparel (bupivacaine liposome injectable suspension; Pacira Pharmaceuticals) as an interscalene brachial plexus block to produce ...

Medically reviewed by Nicholas R. Metrus, MDMedically reviewed by Nicholas R. Metrus, MD A nerve block for migraine headaches involves an injection of a local anesthetic into the base of the skull or ...

A nerve block works by preventing pain signals from reaching the brain. There are permanent and temporary options. Both are generally safe procedures. Nerve blocks are an effective way to prevent, ...